Celldex Therapeutics
CLDX
#4526
Rank
S$2.41 B
Marketcap
$36.10
Share price
-0.63%
Change (1 day)
-1.50%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2023 (TTM): -$3.27

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.23. In 2022 the company made an earnings per share (EPS) of -$3.21 a decrease over its 2021 EPS that were of -$2.21.

EPS history for Celldex Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.271.77%
2022-$3.2145.73%
2021-$2.21-23.36%
2020-$2.88-41.05%
2019-$4.88-76.95%
2018-$21.1845.03%
2017-$14.61-42.54%
2016-$25.42-3.82%
2015-$26.43-0.76%
2014-$26.6329.41%
2013-$20.580%
2012-$20.58-9.73%
2011-$22.801312.5%
2010-$1.61-95.79%
2009-$38.30-49.64%
2008-$76.06-82.64%
2007-$438.18-44.98%
2006-$796.471270.83%
2005-$58.1033.33%
2004-$43.58-10%
2003-$48.42-16.67%
2002-$58.10-38.46%
2001-$94.41-4.88%
2000-$99.26-81.66%
1999-$541.06-87.2%
1998-$4,225206.39%
1997-$1,37913.02%
1996-$1,220

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$5.39 67.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.14-64.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-$16.25 403.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.03-689.58%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.50-177.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.71-245.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$0.77-76.25%๐Ÿ‡บ๐Ÿ‡ธ USA